EUBS Webinar on COVID-19

March 10, 2021  1600-1900 CET

The COVID-19 pandemic has profoundly changed the way we practice diving and how we apply  hyperbaric oxygen therapy. One year after the start of the pandemic, it is time to examine the effects of SARS-CoV2 on our daily practice and how hyperbaric oxygen therapy may even help treat COVID-19 patients.

Please tune in to this EUBS Webinar for a comprehensive overview of the most relevant developments in the last year !

Download the flyer now (EUBS Webinar March 10 2021) and distribute as widely as possible !

Participation is free, only a quick registration is required.

Note that this registration link – as well as the Webinar – will NOT work with Internet Explorer (an obsolete browser) – please use Edge, Chrome, Firefox or Safari.
Participation certificates can be used to claim CME in your own country / region.

Programme:

  • Introduction (Ole Hyldegaard, EUBS President)
  • HBO in COVID-19 times – How is it organized in European HBO centres ? (Benoit Desgraz and Rodrigue Pignel) (40 min)
  • Disinfection of hyperbaric chambers (Jacek Kot) (40 min)
  • Use of HBO for the treatment of COVID-19 (report on ongoing studies)
    – Canadian RCT (Sylvain Boet) (10 min)
    – Swedish RCT (Anders Kjellberg) (10 min)
    – French RCT (Jean-Eric Blatteau) (10 min)
  • Diving in COVID-19 times – How is the situation in Europe and what are the experiences ?
    – Off shore (commercial) diving (Phil Bryson) (10 min)
    – (French) Navy diving (Jean Morin) (10 min)
    – Recreational Diving (Alessandro Marroni and Laura Marroni) (10 min)
  • Discussion / questions (moderated by Jacek Kot / Gerardo Bosco)
  • Conclusion (Ole Hyldegaard)

Presentations:

Sylvain Boet

Dr. Sylvain Boet is a staff anesthesiologist and hyperbaric physician at The Ottawa Hospital and an Associate Professor at the University of Ottawa, Canada. He is also Assistant Dean at the Faculty of Medicine, Ottawa. He completed his training in anesthesiology and intensive care in France in 2005, has extensive experience in pre-hospital emergency medicine, and holds a PhD of Education. Dr. Boet completed a simulation and medical education fellowship at the University of Toronto. His research encompasses two research programs, one in simulation and medical education and the other in hyperbaric medicine.

In his presentation, Dr. Boet will briefly review the pathophysiological rationale and current published clinical evidence that position hyperbaric oxygen therapy (HBOT) as a promising option to treat hypoxemic COVID-19 patients. He will then present a protocol for a multicenter randomized controlled trial to assess the effectiveness of HBOT on hypoxemic COVID-19 patients.

Anders Kjellberg

Dr. Anders Kjellberg is ICU consultant and head of the hyperbaric unit at Karolinska University Hospital. He is chairman of the Swedish and Scandinavian hyperbaric societies. He is also doctoral student in Peter Lindholm’s group Hyperbaric Medicine at Karolinska Institutet, studying biomarkers for dose/effect of hyperbaric oxygen.

Dr Kjellberg is the principal investigator for a randomized controlled clinical trial COVID-19-HBO evaluating Safety and Efficacy of Hyperbaric oxygen for ARDS in patients with COVID-19. He will present the protocol and preliminary results for this multicenter randomized controlled trial.

Jean-Eric Blatteau

Pr Jean-Eric Blatteau, head of department of diving and hyperbaric medicine at Ste Anne military hospital Toulon France, is the Past President of the French society of diving and hyperbaric medicine and current vice-president of EUBS

Pr Blatteau is the principal investigator for a randomized controlled clinical trial evaluating the management by hyperbaric oxygen therapy of SARS-CoV-2 (COVID-19) patients with hypoxaemic pneumonia. The main objective of this study is to assess the effectiveness of HBOT in addition to normal management over the period of normalization of the oxygen requirement (oxygen dependence) in patients with SAR-CoV2 pneumonia not requiring invasive or non-invasive ventilation. Pr Blatteau will briefly present the protocol and preliminary results for this monocentric randomized controlled trial.

Jean Morin

Dr Jean Morin is working at the department of diving and hyperbaric medicine at Ste Anne military hospital Toulon France, he is responsible for the medical control of French military divers.

Preventive measures have been proposed and applied to avoid the risks of contamination by SARS-CoV2 for military diving activities in France. To allow the resumption of diving activities after confirmed infection with SARS-COV2, a compulsory medical examination was introduced by the health service of the French army. Dr Morin will present the results of the medical evaluation in particular the changes observed after paraclinical assessments.